Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside

Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside

Prostate cancer (PCa) is the second most frequent type of cancer in men worldwide, with 288,300 new cases and 34,700 deaths estimated in the United States in 2023. Treatment options for early-stage disease include external beam radiation therapy, brachytherapy, radical prostatectomy, active surveill...

Full description

Bibliographic Details
Main Authors: Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, Wassim Abou-Kheir, Yumna Omarzai, Robert Poppiti
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
prostate cancer
epithelial-to-mesenchymal transition
mesenchymal-to-epithelial transition
EMT
MET
biomarkers
Online Access:https://www.mdpi.com/2072-6694/15/8/2309

Similar Items

Similar Items